English

BIO-KEY INTERNATIONAL, INC.

EDGAR

BKYI Current report (8-K) · filed 2026-10-30

160 filing records in this dataset, filed from 1997-03-31 to 2026-10-30. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.06 million iso4217-usd

2017 Q4 · iso4217-usd

Exact inputs and evidence

Revenue: 6302984 iso4217-usd Source
Revenue: 3247633 iso4217-usd Source

Operating margin

15.58%

2017 Q4 · %

Exact inputs and evidence

Operating Income: -4275365 iso4217-usd Source
Operating Income: -4751321 iso4217-usd Source
Revenue: 6302984 iso4217-usd Source
Revenue: 3247633 iso4217-usd Source

Operating cash flow

-661 thousand iso4217-usd

2017 Q4 · iso4217-usd

Exact inputs and evidence

Operating Cash Flow: -2465462 iso4217-usd Source
Operating Cash Flow: -1804411 iso4217-usd Source

Cash and cash equivalents: 1.38 million USD 2026-06-30 Source
Exact value

1379300 USD
Long-term debt including current maturities: Not available
Shares outstanding: 1.09 million shares 2026-06-30 Source
Exact value

1087360 shares

Reported share-count change

-84.12% · -5.76 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

6848776 shares · 2025-06-30· Source
1087360 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

6.3 million iso4217-usd

2017-01-01 – 2017-12-31

Exact inputs and evidence

Revenue: 1418335 iso4217-usd · 2017-01-01 – 2017-03-31 Source
Revenue: 886881 iso4217-usd · 2017-04-01 – 2017-06-30 Source
Revenue: 942417 iso4217-usd · 2017-07-01 – 2017-09-30 Source
Revenue: 6302984 iso4217-usd · 2017-01-01 – 2017-12-31 Source
Revenue: 3247633 iso4217-usd · 2017-01-01 – 2017-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2017-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2025-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 2.86 million

Prior period

−USD 4.3 million

2024-01-01 – 2024-12-31
Current period

−USD 7.16 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-7157946 − -4300692 = -2857254 USD

-4300692 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-7157946 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIO-KEY INTERNATIONAL, INC. · 2025-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Year-over-year change in Net income: -2857254 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7157946 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1053336 Filing: 000143774926020446 Input fundies:NetIncome: -4300692 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1053925 Filing: 000143774926020446
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.75 million

Prior period

−USD 2.91 million

2024-01-01 – 2024-12-31
Current period

−USD 4.67 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-4668689 − -2914072 = -1754617 USD

-2914072 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-4668689 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIO-KEY INTERNATIONAL, INC. · 2025-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Year-over-year change in Operating cash flow: -1754617 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4668689 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1094981 Filing: 000143774926020446 Input fundies:OperatingCashFlow: -2914072 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1095680 Filing: 000143774926020446
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-7.9%

Prior period

USD 13,047

2024-01-01 – 2024-12-31
Current period

USD 12,012

2025-01-01 – 2025-12-31

Exact inputs and evidence

12012 − 13047 = -1035 USD

13047 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
12012 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIO-KEY INTERNATIONAL, INC. · 2025-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Year-over-year change in Capital expenditure: -1035 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 12012 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1097565 Filing: 000143774926020446 Input fundies:CapitalExpenditure: 13047 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1098252 Filing: 000143774926020446
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue iso4217-usd 6.3 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	5261225	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2015-01-01 – 2015-12-31: 5261225 iso4217-usd Inspect Revenue Open source
2016 2016-01-01 – 2016-12-31	2975756	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2016-01-01 – 2016-12-31: 2975756 iso4217-usd Inspect Revenue Open source
2017 2017-01-01 – 2017-12-31	6302984	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2017-01-01 – 2017-12-31: 6302984 iso4217-usd Inspect Revenue Open source

Amounts are exact, in iso4217-usd.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

iso4217-usd 6.3M 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(iso4217-usd)	Source evidence
20152015-12-31	Revenue	5261225	Revenue: 5261225 Open source
20162016-12-31	Revenue	2975756	Revenue: 2975756 Open source
20172017-12-31	Revenue	6302984	Revenue: 6302984 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

111.8% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 5261225 Open source
20162016-12-31	Year over year	-43.4%	Revenue: 2975756 Open source Revenue: 5261225 Open source
20172017-12-31	Year over year	111.8%	Revenue: 6302984 Open source Revenue: 2975756 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Operating margin	Not reported	Revenue: 5261225 Open source
2016-12-31	Operating margin	Not reported	Revenue: 2975756 Open source
2017-12-31	Operating margin	Not reported	Revenue: 6302984 Open source
2015-12-31	Net margin	Not reported	Revenue: 5261225 Open source
2016-12-31	Net margin	Not reported	Revenue: 2975756 Open source
2017-12-31	Net margin	Not reported	Revenue: 6302984 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 5261225 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 2975756 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 6302984 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(iso4217-usd)	Source evidence
20152015-12-31	Operating cash flow	Not reported	No source recorded
20162016-12-31	Operating cash flow	Not reported	No source recorded
20172017-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Free cash flow	Unavailable	No source recorded
20162016-12-31	Free cash flow	Unavailable	No source recorded
20172017-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	No source recorded
2016-12-31	Liabilities / assets	Not reported	No source recorded
2017-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
2017-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 9.67 million Exact value Exact value: -9673987 USD 2020-01-01 – 2020-12-31: -9673987 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-KEY INTERNATIONAL, INC. · 2020-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Net Income: -9673987 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9673987 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774922007930/bkyi20211231_10k.htm#1780986 Filing: 000143774922007930 The citation records this snapshot. The page link may show a newer release later.	−USD 4.95 million Exact value Exact value: -4950108 USD 2020-01-01 – 2020-12-31: -4950108 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-KEY INTERNATIONAL, INC. · 2020-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Operating Cash Flow: -4950108 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4950108 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774922007930/bkyi20211231_10k.htm#1046391 Filing: 000143774922007930 The citation records this snapshot. The page link may show a newer release later.	USD 35,568 Exact value Exact value: 35568 USD 2020-01-01 – 2020-12-31: 35568 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO-KEY INTERNATIONAL, INC. · 2020-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Capital Expenditure: 35568 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35568 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774922007930/bkyi20211231_10k.htm#1049368 Filing: 000143774922007930 The citation records this snapshot. The page link may show a newer release later.	−USD 4.99 million Calculation and evidence -4950108 − 35568 USD Exact free cash flow: -4985676 USD 2020-01-01 – 2020-12-31: -4950108 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 35568 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO-KEY INTERNATIONAL, INC. · 2020-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Free cash flow: -4985676 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4950108 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774922007930/bkyi20211231_10k.htm#1046391 Filing: 000143774922007930 Input fundies:CapitalExpenditure: 35568 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774922007930/bkyi20211231_10k.htm#1049368 Filing: 000143774922007930 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 5.07 million Exact value Exact value: -5065781 USD 2021-01-01 – 2021-12-31: -5065781 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-KEY INTERNATIONAL, INC. · 2021-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Net Income: -5065781 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5065781 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774923017563/bkyi20230607_s1.htm#1813906 Filing: 000143774923017563 The citation records this snapshot. The page link may show a newer release later.	−USD 8.98 million Exact value Exact value: -8978428 USD 2021-01-01 – 2021-12-31: -8978428 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-KEY INTERNATIONAL, INC. · 2021-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Operating Cash Flow: -8978428 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8978428 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774923017563/bkyi20230607_s1.htm#1244094 Filing: 000143774923017563 The citation records this snapshot. The page link may show a newer release later.	USD 42,024 Exact value Exact value: 42024 USD 2021-01-01 – 2021-12-31: 42024 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO-KEY INTERNATIONAL, INC. · 2021-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Capital Expenditure: 42024 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42024 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774923017563/bkyi20230607_s1.htm#1250258 Filing: 000143774923017563 The citation records this snapshot. The page link may show a newer release later.	−USD 9.02 million Calculation and evidence -8978428 − 42024 USD Exact free cash flow: -9020452 USD 2021-01-01 – 2021-12-31: -8978428 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 42024 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO-KEY INTERNATIONAL, INC. · 2021-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Free cash flow: -9020452 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8978428 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774923017563/bkyi20230607_s1.htm#1244094 Filing: 000143774923017563 Input fundies:CapitalExpenditure: 42024 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774923017563/bkyi20230607_s1.htm#1250258 Filing: 000143774923017563 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 11.91 million Exact value Exact value: -11909903 USD 2022-01-01 – 2022-12-31: -11909903 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-KEY INTERNATIONAL, INC. · 2022-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Net Income: -11909903 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11909903 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774924019357/bkyi20231231_10k.htm#1716996 Filing: 000143774924019357 The citation records this snapshot. The page link may show a newer release later.	−USD 6.23 million Exact value Exact value: -6229034 USD 2022-01-01 – 2022-12-31: -6229034 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-KEY INTERNATIONAL, INC. · 2022-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Operating Cash Flow: -6229034 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6229034 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774924019357/bkyi20231231_10k.htm#1144703 Filing: 000143774924019357 The citation records this snapshot. The page link may show a newer release later.	USD 82,040 Exact value Exact value: 82040 USD 2022-01-01 – 2022-12-31: 82040 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO-KEY INTERNATIONAL, INC. · 2022-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Capital Expenditure: 82040 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 82040 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774924019357/bkyi20231231_10k.htm#1150287 Filing: 000143774924019357 The citation records this snapshot. The page link may show a newer release later.	−USD 6.31 million Calculation and evidence -6229034 − 82040 USD Exact free cash flow: -6311074 USD 2022-01-01 – 2022-12-31: -6229034 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 82040 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO-KEY INTERNATIONAL, INC. · 2022-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Free cash flow: -6311074 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6229034 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774924019357/bkyi20231231_10k.htm#1144703 Filing: 000143774924019357 Input fundies:CapitalExpenditure: 82040 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774924019357/bkyi20231231_10k.htm#1150287 Filing: 000143774924019357 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 8.52 million Exact value Exact value: -8521837 USD 2023-01-01 – 2023-12-31: -8521837 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-KEY INTERNATIONAL, INC. · 2023-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Net Income: -8521837 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8521837 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774925012824/bkyi20241231_10k.htm#1673060 Filing: 000143774925012824 The citation records this snapshot. The page link may show a newer release later.	−USD 3.79 million Exact value Exact value: -3793456 USD 2023-01-01 – 2023-12-31: -3793456 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-KEY INTERNATIONAL, INC. · 2023-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Operating Cash Flow: -3793456 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3793456 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774925012824/bkyi20241231_10k.htm#1141887 Filing: 000143774925012824 The citation records this snapshot. The page link may show a newer release later.	USD 1,000 Exact value Exact value: 1000 USD 2023-01-01 – 2023-12-31: 1000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO-KEY INTERNATIONAL, INC. · 2023-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Capital Expenditure: 1000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774925012824/bkyi20241231_10k.htm#1144607 Filing: 000143774925012824 The citation records this snapshot. The page link may show a newer release later.	−USD 3.79 million Calculation and evidence -3793456 − 1000 USD Exact free cash flow: -3794456 USD 2023-01-01 – 2023-12-31: -3793456 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO-KEY INTERNATIONAL, INC. · 2023-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Free cash flow: -3794456 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3793456 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774925012824/bkyi20241231_10k.htm#1141887 Filing: 000143774925012824 Input fundies:CapitalExpenditure: 1000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774925012824/bkyi20241231_10k.htm#1144607 Filing: 000143774925012824 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 4.3 million Exact value Exact value: -4300692 USD 2024-01-01 – 2024-12-31: -4300692 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-KEY INTERNATIONAL, INC. · 2024-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Net Income: -4300692 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4300692 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1053925 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.	−USD 2.91 million Exact value Exact value: -2914072 USD 2024-01-01 – 2024-12-31: -2914072 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-KEY INTERNATIONAL, INC. · 2024-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Operating Cash Flow: -2914072 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2914072 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1095680 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.	USD 13,047 Exact value Exact value: 13047 USD 2024-01-01 – 2024-12-31: 13047 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO-KEY INTERNATIONAL, INC. · 2024-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Capital Expenditure: 13047 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13047 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1098252 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.	−USD 2.93 million Calculation and evidence -2914072 − 13047 USD Exact free cash flow: -2927119 USD 2024-01-01 – 2024-12-31: -2914072 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 13047 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO-KEY INTERNATIONAL, INC. · 2024-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Free cash flow: -2927119 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2914072 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1095680 Filing: 000143774926020446 Input fundies:CapitalExpenditure: 13047 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1098252 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 7.16 million Exact value Exact value: -7157946 USD 2025-01-01 – 2025-12-31: -7157946 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO-KEY INTERNATIONAL, INC. · 2025-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Net Income: -7157946 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7157946 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1053336 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.	−USD 4.67 million Exact value Exact value: -4668689 USD 2025-01-01 – 2025-12-31: -4668689 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO-KEY INTERNATIONAL, INC. · 2025-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Operating Cash Flow: -4668689 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4668689 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1094981 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.	USD 12,012 Exact value Exact value: 12012 USD 2025-01-01 – 2025-12-31: 12012 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO-KEY INTERNATIONAL, INC. · 2025-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Capital Expenditure: 12012 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12012 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1097565 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.	−USD 4.68 million Calculation and evidence -4668689 − 12012 USD Exact free cash flow: -4680701 USD 2025-01-01 – 2025-12-31: -4668689 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 12012 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO-KEY INTERNATIONAL, INC. · 2025-12-31 BIO-KEY INTERNATIONAL, INC. (edgar:1019034) Free cash flow: -4680701 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:43:34Z Snapshot: 3b6726f905f6232608853fa1153e077b58adce59eab70d76a586a7e06da4ce4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1019034?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4668689 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1094981 Filing: 000143774926020446 Input fundies:CapitalExpenditure: 12012 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1019034/000143774926020446/bkyi20251231c_10k.htm#1097565 Filing: 000143774926020446 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

160 filings · 4,378 latest values · 4,378 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001019034, 1019034, BKYI, bkyi, edgar:1019034

Also known as BIO KEY INTERNATIONAL INC, BIO-KEY INTERNATIONAL, INC., BIO-KEY INTERNATIONAL, INC., BIO-key International, Inc., SAC TECHNOLOGIES INC

BIO-KEY INTERNATIONAL, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation